Metallothionein genes: no association with Crohn's disease in a New Zealand population
1 Discipline of Nutrition, FMHS, The University of Auckland, Auckland, New Zealand
2 Nutrigenomics New Zealand, New Zealand
3 Department of Medicine, FMHS, The University of Auckland, Auckland, New Zealand
Journal of Negative Results in BioMedicine 2012, 11:8 doi:10.1186/1477-5751-11-8Published: 28 January 2012
Metallothioneins (MTs) are excellent candidate genes for Inflammatory Bowel Disease (IBD) and have previously been shown to have altered expression in both animal and human studies of IBD. This is the first study to examine genetic variants within the MT genes and aims to determine whether such genetic variants have an important role in this disease. 28 tag SNPs in genes MT1 (subtypes A, B, E, F, G, H, M, X), MT2, MT3 and MT4 were selected for genotyping in a well-characterized New Zealand dataset consisting of 406 patients with Crohn's Disease and 638 controls. We did not find any evidence of association for MT genetic variation with CD. The lack of association indicates that genetic variants in the MT genes do not play a significant role in predisposing to CD in the New Zealand population.